| P50 | author | Edda Klipp | Q47008744 |
| P2093 | author name string | Christine Sers | |
| | Stefan Kempa | |
| | Guido Mastrobuoni | |
| | Raphaela Fritsche-Guenther | |
| | Nadine Royla | |
| | Matthias Pietzke | |
| | Christin Zasada | |
| | Florian Roßner | |
| | Roman Rainer | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | AMPK phosphorylation of raptor mediates a metabolic checkpoint | Q24329244 |
| | The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates | Q24530120 |
| | The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation | Q24531840 |
| | Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 |
| | Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers | Q26781362 |
| | Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance | Q26795609 |
| | Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function | Q28254826 |
| | Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF | Q28474973 |
| | Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease | Q28611191 |
| | Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors | Q28817880 |
| | MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification | Q29547200 |
| | Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition | Q48348507 |
| | Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism | Q51803667 |
| | Prediction of temporal gene expression. Metabolic opimization by re-distribution of enzyme activities | Q52954618 |
| | Ras-dependent carbon metabolism and transformation in mouse fibroblasts | Q61071496 |
| | Krebszelle und Glycerinaldehyd | Q73716083 |
| | The mechanism by which glyceraldehyde inhibits glycolysis | Q75603055 |
| | ON DESTRUCTION OF CANCER CELLS WITH ROENTGEN RAYS | Q76622657 |
| | Andromeda: a peptide search engine integrated into the MaxQuant environment | Q29615816 |
| | Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics | Q29615818 |
| | THE METABOLISM OF TUMORS IN THE BODY | Q29616202 |
| | Maui-VIA: A User-Friendly Software for Visual Identification, Alignment, Correction, and Quantification of Gas Chromatography-Mass Spectrometry Data. | Q30887960 |
| | The Perseus computational platform for comprehensive analysis of (prote)omics data | Q31110953 |
| | VANTED: a system for advanced data analysis and visualization in the context of biological networks | Q33235611 |
| | Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium | Q33281085 |
| | Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer | Q33967933 |
| | The simultaneous measurement of nicotinamide adenine dinucleotide and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry | Q33994534 |
| | Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells | Q34188530 |
| | Nutrient signaling to mTOR and cell growth | Q34331244 |
| | The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. | Q34415669 |
| | The Warburg Effect: How Does it Benefit Cancer Cells? | Q34509467 |
| | CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors | Q35289071 |
| | Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth | Q35458543 |
| | Tumor cell metabolism: an integral view. | Q35760954 |
| | 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors | Q35778060 |
| | 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants. | Q35879138 |
| | Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling | Q35931606 |
| | Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer | Q35987880 |
| | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | Q37295744 |
| | Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer | Q37593559 |
| | Network quantification of EGFR signaling unveils potential for targeted combination therapy. | Q37660498 |
| | Ras mutational status is a biomarker for resistance to EGFR inhibitors in colorectal carcinoma | Q37813351 |
| | Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations | Q38208069 |
| | Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. | Q38451773 |
| | Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer. | Q38762520 |
| | Pulsed stable isotope-resolved metabolomic studies of cancer cells | Q38985452 |
| | Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin | Q39524587 |
| | Strong negative feedback from Erk to Raf confers robustness to MAPK signalling. | Q39536250 |
| | Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer | Q39563275 |
| | Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors | Q39583739 |
| | Proteomics Quality Control: Quality Control Software for MaxQuant Results | Q40226381 |
| | Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems | Q40769395 |
| | Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer | Q41503593 |
| | Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis | Q42106395 |
| | Decoding the dynamics of cellular metabolism and the action of 3-bromopyruvate and 2-deoxyglucose using pulsed stable isotope-resolved metabolomics | Q42738350 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9204 | |
| P577 | publication date | 2018-06-15 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations | |
| P478 | volume | 8 | |